InsidersTradesSigma
Follow the Cochlear Limited stock price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the oversight of ASX. Operating in the Health Care sector, Cochlear Limited has recorded 18 reports. Market capitalisation: €8.9bn. The latest transaction was filed on 27 August 2026 (Initial Substantial Holding). Among the most active insiders: There was a change in the interests of the. The full history is free.
18
Insider Decl.
n/a
Thresholds
€57,087
5 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cochlear Limited Hold (neutral), based on 16 analysts. Average price target: A$140.04.
39Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,097 of 28,932 companies
52.7
score / 100
Value37
Quality68
FCF yld3.1%
Earn yld1.7%
EV/EBITDA27.5x
ROE8.0%
Gross mgn71%
Net mgn6.3%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 August 2026
Declarations18 total
ShareASXISIN AU000000COH5ASX:2924-03127549-2A1692868
1 shares@ A$96.000.0000% mcap100.0% of flowShareASXISIN AU000000COH5ASX:2924-03127040-2A1692554
1 shares@ A$138.780.0000% mcap100.0% of flowShareASXISIN AU000000COH5ASX:2924-03127037-2A1692549
ShareASXISIN AU000000COH5ASX:2924-03126658-2A1692382
386 shares@ A$138.000.0006% mcap100.0% of flowShareASXISIN AU000000COH5ASX:2924-03125372-2A1691674
1,400 shares@ A$0.09760.0000% mcap100.0% of flowShareASXISIN AU000000COH5ASX:2924-03125369-2A1691670
0@ A$141.000.0038% mcap100.0% of flowShareASXISIN AU000000COH5ASX:2924-03125359-2A1691666
286 shares@ A$139.800.0004% mcap100.0% of flowShareASXISIN AU000000COH5ASX:2924-03125358-2A1691661
19,087 sharesShareASXISIN AU000000COH5ASX:2924-03125357-2A1691655
ShareASXISIN AU000000COH5ASX:2924-03121387-2A1689661
ShareASXISIN AU000000COH5ASX:2924-03120588-2A1689206
ShareASXISIN AU000000COH5ASX:2924-03117944-2A1687601
ShareASXISIN AU000000COH5ASX:2924-03083504-2A1668630
ShareASXISIN AU000000COH5ASX:2924-03083287-2A1668564
ShareASXISIN AU000000COH5ASX:2924-03082752-2A1668372
ShareASXISIN AU000000COH5ASX:2924-03081332-2A1667727
18 of 18 declarations
About Cochlear Limited
Cochlear Limited is a company focused on developing innovative hearing solutions. It specializes in cochlear implants and other technologies to assist individuals with hearing loss.